SOBI:STO
Swedish Orphan Biovitrum AB (publ)
SEK 433,20
arrow_upward
+1,12%(+4,80) 1D
12 ຕ.ລ., 16 ໂມງ 16 ນາທີ 13 ວິນາທີ GMT+2 · SEK
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for SOBI...
Open
SEK 431,00
High
SEK 435,40
Low
SEK 430,00
Mkt. cap
154,93 ຕື້
Avg. vol.
270,18 ພັນ
Volume
50,34 ພັນ
P/E ratio
115,70
52-wk high
SEK 487,00
52-wk low
SEK 293,60
EPS
SEK 3,74
Shares outstanding
357,64 ລ້ານ
No. of employees
2 ພັນ
Open
SEK 431,00
High
SEK 435,40
Low
SEK 430,00
Mkt. cap
154,93 ຕື້
Avg. vol.
270,18 ພັນ
Volume
50,34 ພັນ
P/E ratio
115,70
52-wk high
SEK 487,00
52-wk low
SEK 293,60
EPS
SEK 3,74
Shares outstanding
357,64 ລ້ານ
No. of employees
2 ພັນ
News stories
From web sources and news partners
Yahoo Finance
·
43 ນາທີກ່ອນ
A handful of tech stocks are masking an ugly S&P 500 problem
Macau Business
·
11 ນາທີກ່ອນ
SSA Commissioner Headlines Columbus Day at the NYSE: NYSE Content Update
GlobeNewswire
·
49 ນາທີກ່ອນ
Stewards Inc. to Ring Nasdaq Opening Bell on Oct. 14, Celebrating Company's Next Chapter
24/7 Wall St.
·
35 ນາທີກ່ອນ
Stock Market Today: S&P 500 Futures Pause Near Record Highs as Oil Rises Ahead of Bank Earnings
Profile
Sobi - Swedish Orphan Biovitrum AB is an international biopharmaceutical company focused on rare diseases. The company develops, commercializes, and delivers therapies in the fields of haematology, immunology and specialty care. Headquartered in Stockholm, Sweden, with major hubs in Basel, Switzerland, and Waltham, USA.
Sobi has a global presence in approximately 30 countries and provides medicines to patients in many more around world. The company develops treatments for patients living with complex and chronic rare conditions and maintains a pipeline of development and lifecycle management programs focused on advancing innovative therapies for diseases with significant unmet medical needs. Wikipedia
About Swedish Orphan Biovitrum AB (publ)